La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Zhejiang Tailin BioEngineeringLtd Bilan de santé

Santé financière contrôle des critères 0/6

Informations clés

25.8%

Ratio d'endettement

CN¥167.87m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	CN¥300.04m
Fonds propres	CN¥650.83m
Total du passif	CN¥298.82m
Total des actifs	CN¥949.65m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up

May 09

Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up

Mar 08

Zhejiang Tailin BioEngineeringLtd Bilan de santé

Santé financière contrôle des critères 0/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

New major risk - Revenue and earnings growth

Second quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.05 in 2Q 2023)

Zhejiang Tailin BioEngineering Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up

Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Zhejiang Tailin BioEngineering Co.,Ltd, Annual General Meeting, May 14, 2024

New minor risk - Profit margin trend

Investor sentiment deteriorates as stock falls 26%

Investor sentiment improves as stock rises 20%

Zhejiang Tailin BioEngineering Co.,Ltd to Report Q1, 2024 Results on Apr 24, 2024

Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Zhejiang Tailin BioEngineering Co.,Ltd to Report Fiscal Year 2023 Results on Apr 24, 2024

Third quarter 2023 earnings released: CN¥0.019 loss per share (vs CN¥0.15 profit in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.05 (vs CN¥0.16 in 2Q 2022)

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.22 in 2Q 2021)

Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022

First quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.18 in 1Q 2021)

Less than half of directors are independent

Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021

Full year 2021 earnings released: EPS: CN¥1.22 (vs CN¥0.95 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.28 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.22 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2020, Payable on May 26 , 2021

Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Dividend for 2020

Full year 2020 earnings released: EPS CN¥0.95 (vs CN¥0.88 in FY 2019)

New 90-day low: CN¥39.65

New 90-day low: CN¥40.01

Investor sentiment deteriorated over the past week

New 90-day low: CN¥46.35

New 90-day low: CN¥52.83

New 90-day low: CN¥60.04

Third quarter earnings released

First half earnings released

Zhejiang Tailin BioEngineering Co.,Ltd to Report First Half, 2020 Results on Aug 28, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines